Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Chubb
Federal Trade Commission
Deloitte
Moodys
Julphar

Generated: August 17, 2019

DrugPatentWatch Database Preview

Claims for Patent: 5,866,793

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,866,793
Title: Promoter for expressing foreign genes in monocotyledonous plants
Abstract:A DNA fragment for directing the expression of foreign or endogenous genes or RNA in cells of monocot plants. The fragment comprises a sequence corresponding to a first part of a putative type I starch branching enzyme gene (wbeI) present in wheat and a 5\'-region upstream of the gene, or a part of the sequence that is effective for increasing the expression of the foreign or endogenous gene in the plant cells. The indicated sequence contains two promoter regions, P1 and P2. A DNA fragment effective to increase expression comprises at least one of the promoter regions, or an effective part. The fragment can be obtained from a genomic library of wheat and can be fused to suitable genes and markers and inserted into suitable vectors for expression in transgenic monocot plants.
Inventor(s): Baga; Monica (Saskatoon, CA), Chibbar; Ravindra N. (Saskatoon, CA), Kartha; Kutty K. (Saskatoon, CA)
Assignee: National Research Council of Canada (Ottawa, CA)
Application Number:08/773,251
Patent Claims:1. A DNA fragment for directing the expression of foreign or endogenous genes in cells of monocot plants, said fragment comprising the sequence of a part of a type I starch branching enzyme gene (wbeI) present in wheat, which part is a 3'-region downstream commencing at an ATG start codon for translation of said gene, and a 5'-region upstream of said ATG start codon, or a part of said sequence, said sequence or said part thereof being effective to cause expression of said foreign or endogenous gene in said cells at a level higher than is possible in the absence of said sequence or part thereof, wherein said DNA fragment is a sequence derived from a plasmid pBE64:8-2.

2. A DNA fragment according to claim 1 comprising at least one of two promoter regions, P1 and P2, a first of said promoters P1 being positioned upstream of said ATG start codon and a second of said promoters P2 being positioned downstream of said start codon.

3. A DNA fragment according to claim 1 wherein said starch branching enzyme gene comprises first and second introns and said DNA sequence includes first and second promoter regions P1 and P2, one promoter region P1 being located in said 5' upstream region and the other promoter region P2 being located in said second intron.

4. A DNA fragment for directing the expression of foreign or endogenous genes in cells of monocot plants, said fragment comprising the sequence of a part of a type I starch branching enzyme gene (wbeI) present in wheat, which part is a 3'-region downstream commencing at an ATG start codon for translation of said gene, and a 5'-region upstream of said ATG start codon, or a part of said sequence, said sequence or said part thereof being effective to cause expression of said foreign or endogenous gene in said cells at a level higher than is possible in the absence of said sequence or part thereof, said DNA fragment having a swquence comprising at least a part of SEQ ID NO:1.

5. A DNA fragment according to claim 4 comprising at least SEQ ID NO:4.

6. A DNA fragment according to claim 4 comprising at least SEQ ID NO:12.

7. A DNA fragment according to claim 4 comprising at least SEQ ID NO:3.

8. A DNA fragment according to claim 4 comprising SEQ ID NO:5.

9. A DNA fragment according to claim 4 comprising SEQ ID NO:6.

10. A construct comprising a DNA fragment linked to a gene other than wbeI, said fragment being the sequence of a part of a type I starch branching enzyme gene (wbeI) present in wheat, which part is a 3'-region downstream commencing at an ATG start codon for translation of said gene, and a 5'-region upstream of said ATG start codon, or a part of said sequence, said sequence or said part thereof being effective to cause expression of said foreign or endogenous gene in said cells at a level higher than is possible in the absence of said sequence or part thereof, wherein said DNA fragment has a sequence comprising at least a part of SEQ ID NO:1.

11. A construct according to claim 10 further comprising a polyadenylation sequence transcriptionally fuse to said gene.

12. A construct according to claim 10 further comprising a selectable marker gene that is under the control of a constitutive promoter.

13. A vector for introducing a foreign or endogenous gene into a genome of a monocot plant, comprising a DNA fragment comprising a part of a type I starch branching enzyme gene (wbeI) present in wheat, which part is a 3'-region downstream commencing at an ATG start codon for translation of said gene, and a 5'-region upstream of said ATG start codon, or a part of said sequence, said sequence or said part thereof being effective to cause expression of said foreign or endogenous gene in said cells at a level higher than is possible in the absence of said sequence or part thereof, and wherein said DNA fragment has a sequence comprising at least a part of SEQ ID NO:1.

14. A vector according to claim 13 further comprising a foreign or endogenous gene and a polyadenylation sequence transcriptionally fused to said foreign or endogenous gene.

15. A vector according to claim 13 further encoding a gene encoding a selectable marker under the control of a constitutive promoter.

16. The vector designated pGK101.

17. The vector designated pGK102.

18. The vector designated pGK105.

19. The vector designated pGK107.

20. A plant cell having a genome containing a foreign gene or an endogenous gene other than wbeI under expression control of a promoter, said promoter including a DNA sequence comprising a part of a 3'-region of wbeI gene present in wheat commencing at an ATG start codon for translation of said wbeI gene and a 5'-region upstream of said ATG start codon, wherein said sequence comprises at least a part of SEQ ID NO:1.

21. A transgenic plant containing a foreign gene or an endogenous gene other than wbeI, under expression control of a promoter, said promoter including a DNA sequence comprising a part of a 3'-region of wbeI present in wheat commencing at an ATG start codon for translation of said wbeI gene and a 5'-region upstream of said ATG start codon, wherein said sequence comprises at least a part of SEQ ID NO:1.

22. A method of producing transgenic monocot plants, which comprises introducing a vector comprising a foreign or endogenous gene and a DNA sequence of a part of a type I starch branching enzyme gene (wbeI) present in wheat, which part is a 3'-region downstream commencing at an ATG start condon for translation of said gene and a 5'-region upstream of said ATG start codon, or a part of said sequence, said sequence or said part thereof being effective to cause expression of said foreign or endogenous gene at a level higher than is possible in the absence of said sequence or part thereof, into a totipotent explant of a monocot plant to form a transformed explant, and culturing the transformed explant to form a mature transgenic monocot plant, wherein said sequence comprises at least a part of SEQ ID NO:1.

23. A method according to claim 22, wherein said totipotent explant is a zygotic embryo from which the embryo axis has been detached.

24. An isolated, genetically transformed totipotent explant of a monocot plant comprising a foreign or endogenous gene and a DNA sequence of a part of a type I starch branching enzyme (wbeI) present in wheat, which part is a 3'-region downstream commencing at an ATG start codon for translation of said gene, and a 5'-region upstream of said ATG start codon, or a part of said sequence, said sequence or said part thereof being effective to cause expression of said foreign or endogenous gene in plants developed from said explant at a level higher than is possible in the absence of said sequence or part thereof, said totipotent explant being a zygotic embryo from which the embryo axis has been detached, and wherein said sequence comprises at least a part of SEQ ID NO:1.

Summary for Patent:   Try a Free Trial

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Canada2178016Jun 3, 1996

Details for Patent 5,866,793

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial National Research Council of Canada (Ottawa, CA) 2016-06-03 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial National Research Council of Canada (Ottawa, CA) 2016-06-03 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial National Research Council of Canada (Ottawa, CA) 2016-06-03 RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 5,866,793

Country Patent Number Publication Date
Canada 2196834 Dec 04, 1997
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
UBS
QuintilesIMS
Farmers Insurance
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.